0001104659-24-027016.txt : 20240223 0001104659-24-027016.hdr.sgml : 20240223 20240223160627 ACCESSION NUMBER: 0001104659-24-027016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Busch Jeffrey CENTRAL INDEX KEY: 0001620772 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37815 FILM NUMBER: 24671154 MAIL ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Medical REIT Inc. CENTRAL INDEX KEY: 0001533615 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 464757266 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 202-524-6851 MAIL ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SCOOP MEDIA, INC. DATE OF NAME CHANGE: 20111027 4 1 tm247073-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-21 0 0001533615 Global Medical REIT Inc. GMRE 0001620772 Busch Jeffrey 7373 WISCONSIN AVENUE, SUITE 800 BETHESDA MD 20814 1 1 0 0 Chairman, President and CEO 0 LTIP Unit (Right to Buy) 2024-02-21 4 A 0 62176 0 A Common Stock 62176 692018 D LTIP Unit (Right to Buy) 2024-02-21 4 A 0 29384 0 A Common Stock 29384 721402 D Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 21, 2027, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.2 to the Issuer's Quarterly Report on Form 10-Q filed on May 5, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Represents LTIP Units in the OP. The Issuer's Board of Directors determined that on February 21, 2024, 50% of the LTIP Units became vested and nonforfeitable on February 21, 2024 as a result of meeting certain market-based performance criteria as of December 31, 2023, and 50% of the LTIP Units will vest on February 21, 2025 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on August 4, 2023. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. /s/ Jamie Barber, as Attorney-in-Fact 2024-02-23